CURRENT ISSUES OF CONTROL OF ARTERIAL HYPERTENSION AND LIPID DISORDERS: FOCUS ON ADHERENCE TO THE TREATMENT


D.V. Nebieridze, A.F. Sarycheva, T.V. Kamyshova

FSBI SRC of Preventive Medicine of RMPH, Moscow
The article presents the results of the study aimed to the assessment of effectiveness of therapy with a fixed combination of amlodipine and atorvastatin Duplecor in patients with arterial hypertension (AH) and associated dyslipidemia (DLE). It has been shown that the use of a fixed combination Duplecor is convenient, safe and effective approach to the simultaneous control of two major cardiovascular risk factors. Easy to administrate formulation - one tablet instead of two tablets - can greatly simplify the treatment of AH and DLE, and therefore improve patient’s adherence to drug therapy.

About the Autors


D.V. Nebieridze – MD, Prof. Head of the Division of the Prevention of Metabolic Disorders FSBI SRC of Preventive Medicine of RMPH; e-mail: dneberidze@gnicpm.ru
A.F. Sarycheva – physician at the FSBI Clinical Hospital №1, Moscow
T.V. Kamyshova – PhD in Medical Sciences, Senior Researcher at the Division of the Prevention of Metabolic Disorders FSBI SRC of Preventive Medicine of RMPH


Similar Articles


Бионика Медиа